SCHEMBL8010

SCHEMBL8010

C[N+](C)(C)CC(O)P(=O)(O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.41
MAPT P10636 3/20 0.39
SLC22A16 Q86VW1 1/20 0.39
LAP3 P28838 3/20 0.33
TSHR P16473 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM1 P11229 2/20 0.33
FDPS P14324 2/20 0.33
TBXA2R P21731 1/20 0.33
LMNA P02545 2/20 0.32
CPT2 P23786 1/20 0.32
CPT1A P50416 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32
CYP2C9 P11712 1/20 0.32
GALR3 O60755 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14742785 1.00 BBOX1 (0.41) BBOX1MAPTSLC22A16LAP3TSHR
Bromide SCHEMBL8416789 0.97 BBOX1 (0.39) BBOX1MAPTSLC22A16LAP3TSHR
Water SCHEMBL17373732 0.97 BBOX1 (0.39) BBOX1MAPTSLC22A16LAP3TSHR
Hydrochloric Acid SCHEMBL434365 0.97 MAPT (0.43) BBOX1MAPTSLC22A16LAP3TSHR
Hydrochloric Acid SCHEMBL2355625 0.95 MAPT (0.41) BBOX1MAPTSLC22A16LAP3TSHR
Hydroxyamine SCHEMBL8584616 0.95 BBOX1 (0.43) BBOX1MAPTSLC22A16LAP3TSHR
Hydrochloric Acid SCHEMBL933391 0.95 MAPT (0.41) BBOX1MAPTSLC22A16LAP3TSHR
Phosphoric Acid SCHEMBL9095324 0.93 BBOX1 (0.41) BBOX1MAPTSLC22A16TSHRCHRM2
Glycerin SCHEMBL691939 0.89 SLC22A16 (0.42) BBOX1MAPTSLC22A16LMNASMN1; SMN2
Hexane SCHEMBL3645235 0.89 FDPS (0.47) BBOX1LAP3FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12411 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144759-A1 Surface-modified plant-derived extracellular vesicles and targeted drug delivery system using the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2026-05-28 US claimed
EP-4746852-A1 LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION Universität Bern (CH) 2026-05-27 EP claimed
CN-122072264-A Serum metabolite composition, kit and application 中国科学院大连化学物理研究所 2026-05-22 CN claimed
WO-2026106498-A1 PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES NanoSanguis S.A. (PL) 2026-05-21 WO claimed
WO-2026103832-A1 LIPID THIN FILM, LIPOSOME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 远大赛威信生命科学(南京)有限公司 2026-05-21 WO claimed
EP-4744487-A1 FLUID, METHODS OF PRODUCING FLUID, AND ITS USES NanoSanguis S.A. (PL) 2026-05-20 EP claimed
EP-4744486-A1 PERFUSION FLUID, METHODS OF PRODUCING PERFUSION FLUID, AND ITS USES. NanoSanguis S.A. (PL) 2026-05-20 EP claimed
EP-4743437-A1 DIESTER LIPIDS, LIPID NANOPARTICLE CONTAINING DIESTER LIPIDS, AND FORMULATIONS THEREOF Providence Therapeutics Holdings Inc. (CA) 2026-05-20 EP claimed
WO-2026097417-A1 LIQUID COMPOSITION FOR CONTACT LENSES AND CONTACT LENS PRODUCT 晶硕光学股份有限公司 2026-05-15 WO claimed
WO-2026098473-A1 IONIZABLE CATIONIC LIPID, AND PREPARATION METHOD THEREFOR AND USE THEREOF 汉信生物科技(苏州)有限公司 2026-05-15 WO claimed
WO-1992016639-A1 REGIOSELECTIVE SYNTHESIS OF 1,3-DISUBSTITUTED GLYCERIDES THE PROCTER & GAMBLE COMPANY (US) 1992-10-01 WO claimed
US-5137660-A Regioselective synthesis of 1,3-disubstituted glycerides THE PROCTER & GAMBLE COMPANY (US) 1992-08-11 US claimed
EP-0435911-A1 CELL CULTURE MEDIUM FOR ENHANCED CELL GROWTH, CULTURE LONGEVITY AND PRODUCT EXPRESSION. CETUS CORP (US) 1991-07-10 EP claimed
US-4990291-A Method of making lipid tubules by a cooling process THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1991-02-05 US claimed
CN-1046848-A Phospholipid-water preparation and its production and application NATTERMANN A & CIE (DE) 1990-11-14 CN claimed
WO-1990003430-A1 CELL CULTURE MEDIUM FOR ENHANCED CELL GROWTH, CULTURE LONGEVITY AND PRODUCT EXPRESSION CETUS CORPORATION (US) 1990-04-05 WO claimed
US-4839275-A DIAGNOSIS OF DOG HEARTWORMS THE JEWISH HOSPITAL (US) 1989-06-13 US claimed
US-4684632-A Formulation with special 1,2-diacylglycero-3-phosphocholines for the treatment of gastrointestinal disorders A. NATTERMANN & CIE. GMBH (DE) 1987-08-04 US claimed
CN-85104003-A The method that plant growth regulator and increase output and promotion root generate 1986-11-19 CN claimed
US-4351831-A Process and composition for treating disorders by administering isoxsurpine and choline MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1982-09-28 US claimed